A long-forgotten candidate for antiviral therapy is undergoing a renaissance: Since the 1970s, the small molecule CMA has been considered a potent agent against viral infections, yet it was never approved for clinical use.
http://www.medicalnewstoday.com/releases/259440.php
http://www.medicalnewstoday.com/releases/259440.php
No comments:
Post a Comment